Search the Newsreel

Granite Point to stream Q2 results review online Aug. 6

Rani Therapeutics CEO Talat Imran buys $25,193 in stock

Rani Therapeutics CEO Talat Imran recently purchased 35,000 shares of the company's Class A Common Stock for $25,193, following a 49% stock decline over six months. This transaction increases his direct holdings to 469,736 shares, with the stock still showing a 65% return over …

ORN vs. ROAD: Which Infrastructure Stock Has More Upside Potential?

Infrastructure investment remains one of the strongest long-term themes in the U.S. construction market, supported by federal transportation funding, defense-related spending, data center expansion and continued population growth across high-growth regions. Companies with specialized capabilities, disciplined execution and healthy project pipelines stand to benefit …

American Uranium Limited Issues 114,583 Shares Under Section 708A Relief Provisions

American Uranium Ltd Issues 114,583 Shares in Exchange for Marketing Services

Rani Therapeutics Holdings (NASDAQ:RANI) surges 29%, shrinking Nasdaq compliance deficit to 11%

Uranium Royalty Corp. (UROY) Rallies 2.93% as Nuclear Demand Narrative Gains Traction - Break of Structure

What's Going On With Mega Uranium Ltd. Stock Wednesday?

American Uranium Limited Announces Issuance of 114,583 Shares Under Section 708A Exemption

Rani Therapeutics (RANI) CTO records stock sale and tax withholding

Rani Therapeutics' Chief Technical Officer, Alireza Javadi, reported two dispositions of Class A Common Stock, totaling 695 shares, to cover tax withholding obligations related to restricted stock unit settlements. These transactions, one sale of 386 shares at $0.78 and one withholding of 309 shares …

Rani Therapeutics (RANI) CEO logs RSU-related tax share sales

Rani Therapeutics CEO Imran Talat reported a sale of 8,014 Class A shares on December 27, 2024, at $1.41 to cover tax withholding on restricted stock unit settlements. Additionally, 52,001 shares were withheld or surrendered between June 2025 and June 2026 for the same …

Rani Therapeutics (RANI) grants 2M stock options to its CFO

Rani Therapeutics Holdings, Inc. announced that its CFO, Nicholas Maestas, was granted 2,000,000 stock options for Class A common stock on July 17, 2026. The options have an exercise price of $0.6973 per share and expire on July 16, 2036. The vesting schedule includes …

Granite Construction Contends with Earthquake Risk, Floods, 90-Ft. Drop to Build New Bridge in Everett : CEG

Granite Construction successfully replaced the aging Edgewater Bridge in Everett, Washington, a project complicated by earthquake risks, steep slopes, floods, and a 90-foot drop. The new $27 million precast concrete girder bridge is wider, accommodating two-way traffic, walkers, and bikers, and is designed to …

Rani Therapeutics (RANI) CEO purchases 35,000 shares in open-market trade

Madhav Copper Share Price Forecast: 3 Year Outlook to 2030

Sprott sees buying opportunity as uranium stocks trail market

Uranium Royalty shareholders approve Sweetwater merger deal

Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) shareholders have overwhelmingly approved the acquisition of trona royalty assets from entities affiliated with Orion Resource Partners and Ontario Teachers’ Pension Plan. The transaction, valued at approximately $1.14 billion, will result in the combined entity operating under …

Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rani Therapeutics announced an inducement grant of a stock option to its new Chief Financial Officer, Nicholas Maestas. The option is to purchase 2,000,000 shares of Class A common stock at an exercise price of $0.6973 per share, vesting over four years. This grant …

Uranium Royalty Acquires Existing Royalty on Cameco's Advanced Stage Millennium and Cree Extension Uranium Projects

Uranium Royalty Corp. (URC) has acquired an existing net profit interest (NPI) royalty of 10% on Cameco's Millennium and Cree Extension Uranium Projects in Saskatchewan, Canada, for $6 million. The Millennium Project is an advanced-stage conventional uranium project with significant indicated and inferred resources, …

Shareholders Back Uranium Royalty Arrangement; Court Order Pending

Uranium Royalty Corp. (NASDAQ: UROY, TSX: URC) has received shareholder approval for its arrangement with affiliated entities of Orion Resource Partners and HRG Metals LP, with approximately 99.43% of votes in favor. This arrangement will combine Uranium Royalty Corp. and the Sweetwater Entities under …

Rani Therapeutics’ New CFO Receives 2M-Share Stock Option

Rani Therapeutics has granted its new Chief Financial Officer, Nicholas Maestas, a stock option to purchase 2,000,000 shares of Class A common stock. This inducement grant was made on July 17, 2026, with an exercise price matching the closing price of $0.6973 per share …

Sterling vs. Granite: Which Construction Stock Is a Buy Now?

This article compares Sterling Infrastructure (STRL) and Granite Construction (GVA), two construction stocks benefiting from increased infrastructure spending. Sterling is highlighted for its focus on high-growth mission-critical infrastructure like data centers, showing strong revenue and earnings growth and a premium valuation. Granite offers a …

Uranium Royalty Corp. Obtains Shareholder Approval for Arrangement and Provides Corporate Update

Uranium Royalty Corp. (URC) has announced shareholder approval for a plan of arrangement merging URC with Sweetwater Entities under a new parent company, New URC, incorporated in Delaware. The arrangement, which had 99.43% shareholder approval, is expected to close around July 27, 2026, with …

ETFs Investing in Rani Therapeutics Holdings, Inc. Class A Stocks

This article lists several ETFs that invest in Rani Therapeutics Holdings, Inc. Class A stocks. It provides details such as market value, weight, issuer, management style, focus, expense ratio, AUM, price, and performance for each ETF. The ETFs primarily focus on the healthcare and …

Granite Construction (GVA) Pulls Back As Infrastructure Growth Narrative Points To Undervalued Stock

Granite Construction (GVA) has experienced a 15% stock price pullback recently, despite strong long-term returns, leading to questions about whether it's adjusting to fundamentals or just a temporary dip. A popular narrative suggests the stock is 25.8% undervalued with a fair value of $167.20, …

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Urogen Pharma (URGN) and vTv Therapeutics (VTVT)

This article highlights bullish sentiments from three analysts on healthcare companies Rani Therapeutics Holdings (RANI), Urogen Pharma (URGN), and vTv Therapeutics (VTVT). H.C. Wainwright reiterated a Buy rating for Rani Therapeutics with an $11.00 price target, and also for Urogen Pharma with a $45.00 …

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Fractyl Health, Inc. (GUTS)

Healthcare analysts have provided bullish ratings for Rani Therapeutics Holdings (RANI) and Fractyl Health, Inc. (GUTS). Edward Nash of Canaccord Genuity maintained a Buy rating for Rani with a $5.00 price target, while Whitney Ijem from Canaccord Genuity also maintained a Buy rating for …

Granite REIT Declares Distribution for July 2026

TORONTO, July 17, 2026--(BUSINESS WIRE)--Granite Real Estate Investment Trust ("Granite") (TSX: GRT.UN) announced today that its board of trustees has declared a distribution of CDN $0.2958 per unit for the month of July 2026. The distribution will be paid by Granite on August 14, …

Granite Point Mortgage Trust (NYSE:GPMT) Now Covered by Analysts at UBS Group

UBS Group has initiated coverage on Granite Point Mortgage Trust (NYSE:GPMT) with a "neutral" rating and a $1.50 price target. This brings the stock's average analyst rating to "Reduce" with an average target price of $1.83. Despite the cautious sentiment, Granite Point Mortgage Trust …

H.C. Wainwright reiterates Uranium Royalty stock rating ahead of vote

H.C. Wainwright has reiterated its Buy rating and $4.50 price target for Uranium Royalty (NASDAQ:UROY) ahead of a shareholder vote on a significant transaction. The proposed arrangement involves combining the company with Orion and Ontario Teachers’ royalty interest, forming a larger, cash-flowing entity. The …

Uranium Royalty (NASDAQ:UROY) Raised to "Strong-Buy" at Zacks Research

Zacks Research has upgraded Uranium Royalty (NASDAQ: UROY) from a "hold" to a "strong-buy" rating. This upgrade contributes to a "Buy" consensus rating for the stock, with one Strong Buy, one Buy, and one Hold from different analysts. The article also details the company's …

Granite sets Q2FY26 earnings release for July 30

Granite Construction Incorporated will release its Q2FY26 financial results on July 30, 2026, before market open. The company will host an investor conference call at 8:00 a.m. PT on the same day to discuss its performance. A webcast and telephonic replay will be available, …

Investors Can Hear Granite's July 30 Earnings Call Live

Granite (NYSE: GVA) announced that it will release its financial results for the quarter ended June 30, 2026, before market open on Thursday, July 30, 2026. The company will host an investor conference call the same day at 8:00 a.m. PT. Investors can listen …

Is Granite Construction (GVA) Using the Keystone Bridge Win to Recast Its Infrastructure Identity?

Granite Construction's joint venture, Keystone Bridge Partners, secured a preconstruction services contract for the US$50-$60 million Keystone Avenue Bridge Replacement Project in Reno, Nevada. This win, alongside another significant CMAR award in Washoe County, highlights Granite's increasing involvement in complex, large-scale alternative delivery transportation …

Othello awards Granite Construction Kiwanis Park trails project

The City of Othello has awarded the Kiwanis Park Trails Project to Granite Construction Company to improve existing pathways, making them safer and more accessible. Enhancements will include wider, smooth pavement, wheelchair accessibility, and lighting. This project is part of a larger park improvement …

Elevate Uranium (ASX:EL8) Climbs as Uranium Bulls Revisit ASX Explorers